Therefore, these findings indicate that nanodrugs can induce the conversion of M2-like TAMs to M1 macrophages by regulating the STAT1/3 signaling pathway, thereby promoting anti-tumor immune responses and inhibiting the growth and metastasis of tumor cells. Here, STAT1 is linked to neoplasm.